🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsLab Results & BiomarkersLipid panel improvements mega-thread — share your numbers

Lipid panel improvements mega-thread — share your numbers

LipidDoc_ATL Mon, Jun 8, 2026 at 3:47 AM 19 replies 468 viewsPage 1 of 4
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Jun 8, 2026 at 3:47 AM#1

I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something to compare against.

What I am after is how often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning.

Not looking for reassurance. Looking for the part I have got wrong.

1 4rachel_ABQ
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Jun 8, 2026 at 3:49 AM#2

Answering the narrow version, because the broad one does not have a single answer. A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin and B12, and a full blood count. That set catches the things that change, the things that explain symptoms, and the things that alter the prescribing decision. Almost everything else on the long circulating lists is either invariant, uninterpretable without a specific question, or an incidental finding waiting to cause an unnecessary workup.

Last edited: Jun 8, 2026 at 4:49 AM
2 5roxy_nash, tony_orlando
Reply Quote Save Share Report
mike_mealprep
Member
412
1,890
Jul 2024
Chicago, IL
Jun 8, 2026 at 3:50 AM#3
sarah.morrison said:
A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin…

sarah.morrison has the substance of this right. The condition it depends on is worth stating. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.

Last edited: Jun 8, 2026 at 9:50 AM
3 6Dr.AddMedPHL, newstart_MO, mia_MS2
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jun 8, 2026 at 3:52 AM#4
LipidDoc_ATL said:
I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something…

This matches mine closely enough to be worth saying so. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.

4 7Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 1 other
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Jun 8, 2026 at 4:01 AM#5

Adding the clinical framing, because it changes how the question reads.

Blood work came back perfect. baseline bloodwork + this community = winning. 🏆

5 8Dr.ObesityLA, NurseKim_ATL, paul_denver and 2 others
Reply Quote Save Share Report

Similar Threads

Optimal lab testing frequency on GLP-1 — evidence-based schedule5 replies
A1C from 7.2 to 5.1 — my bloodwork transformation19 replies
Thyroid function monitoring on GLP-1 — TSH and free T4 trends3 replies
Liver enzymes trending down on GLP-1 — ALT/AST normalization17 replies
Kidney function on semaglutide — eGFR and UACR improvements21 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register